PRESENTATION

Q1 2023 — Earnings presentation

Q1 2023PDF · 20 pages1.7 MB
2023 First Quarter Earnings
(unaudited)
Mike Roman
Chairman of the Board &
Chief Executive Officer
Monish Patolawala
Executive Vice President,
Chief Financial &
Transformation Officer
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 1 of 20 --

2
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Forward-looking statements
This presentation contains forward-looking information about 3M’s financial results and estimates and business prospects that involve substantial risks and uncertainties. You can
identify these statements by the use of words such as “anticipate,” “estimate,” “expect,” “aim,” “project,” “intend,” “plan,” “believe,” “will,” “should,” “could,” “target,” “forecast” and
other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could
cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions
and other factors beyond the Company’s control, including inflation, recession, military conflicts, natural and other disasters or climate change affecting the operations of the
Company or its customers and suppliers; (2) risks related to unexpected events such as the public health crises associated with the coronavirus (COVID-19) global pandemic; (3)
foreign currency exchange rates and fluctuations in those rates; (4) risks related to certain fluorochemicals, including liabilities related to claims, lawsuits, and government regulatory
proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company’s plans to exit PFAS manufacturing and discontinue use of PFAS
across its product portfolio; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company’s Annual
Report on Form 10-K for the year ended Dec. 31, 2022 and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and customer preferences; (7)
the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to
shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays with the phased implementation of a global
enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company’s information technology infrastructure; (10) the impact of acquisitions,
strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including
the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market
risks that may affect the Company’s funding obligations under defined benefit pension and postretirement plans; (13) the Company’s credit ratings and its cost of capital; (14) tax-
related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the proposed spin-off of the Company’s Health Care business, including whether
the transaction will be completed, or if completed, will be on the expected terms; the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will
exceed the anticipated amounts; the ability to satisfy the various closing conditions; potential business disruption; the diversion of management time; the impact of the transaction (or
its pendency) on the Company’s ability to retain talent; potential impacts on the Company’s relationships with its customers, suppliers, employees, regulators and other counterparties;
the ability to realize the desired tax treatment (including whether an Internal Revenue Service private letter ruling will be sought or obtained); the risk that any consents or approvals
required will not be obtained; risks associated with financings that may be undertaken and indebtedness that may be incurred in connection with the transaction; and (16) matters
relating to the voluntary chapter 11 proceedings of the Company’s subsidiary Aearo Technologies and certain of its affiliates. Changes in such assumptions or factors could produce
significantly different results. A further description of these factors is located in the Reports under “Cautionary Note Concerning Factors That May Affect Future Results” and “Risk
Factors” in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no obligation to update any forward-looking
statements discussed herein as a result of new information or future events or developments.
Note on non-GAAP financial measures
This presentation refers to certain non-GAAP financial measures. Refer to 3M’s April 25, 2023, press release for descriptions of non-GAAP financial measures such as adjusted net
sales (and adjusted sales change); adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted net cash provided by (used in)
operating activities; adjusted free cash flow; adjusted free cash flow conversion; net debt; adjusted EBITDA (and adjusted EBITDA margin); and various measures that adjust for the
impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-GAAP financial measures
to the most directly comparable GAAP financial measures can be found in that press release.

-- 2 of 20 --

3
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Streamlining and simplifying 3M to drive growth,
margins, and cash
• Improve cost structure and expand margins
– Reduce corporate costs and management layers
– Simplify supply chain to better align how we plan, source, make and deliver
– Streamline go-to-market models to more closely align with customers
– Prioritize geographies and leverage digital engagement capabilities
• Prioritize high growth markets and deliver improved supply chain performance
– Focus on high growth markets: automotive electrification, personal safety,
home improvement, semiconductors, and health care
– Invest in emerging areas: climate technology, industrial automation, next-
generation electronics, and sustainable packaging
– Accelerate factory automation and drive improvements in network
optimization of our plants and distribution centers
• Aligning leadership to future direction of 3M
• Reducing headcount by
~6,000 roles across the global
organization in addition to
previously announced
reduction of 2,500 roles in
global manufacturing
• Expected annual run-rate
improvement in operating
income of $700M to $900M
• Anticipated total pre-tax
charges of $700M to $900M

-- 3 of 20 --

4
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Remain focused on our strategies while
managing in a challenging environment
• Q1 performance
– End-market trends played out as anticipated; significant weakness in
consumer electronics and consumer retail; continued strength in
automotive, automotive aftermarket, electrical markets, and abrasives
– Relentlessly focused on serving customers; decline in disposable respirator
demand and exit of Russia in-line with expectations
– Aggressively managed costs and spending discipline; prioritized
investments in productivity
• Continued focus on our strategic objectives
– Advancing Health Care separation workstreams
– Executing on the exit of PFAS manufacturing
– Progressing on legal matters
• Full-year 2023 guidance remains unchanged
Adjusted organic growth
-5.6%
Includes ~(3.4) ppt headwind from disposable
respirator decline and 2022 exit of Russia
Adjusted operating margin
17.9%
Adjusted earnings per share
$1.97

-- 4 of 20 --

5
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Q1 2023 operating margin and EPS
Adjusted
operating
margin
Adjusted
earnings
per share Commentary
Q1 2022 22.0% $2.63
Total organic growth/
productivity/other -2.0% -$0.38
Disposable respirator/Russia exit -1.1% -$0.21 • Decline in COVID-related disposable respirator demand; 2022 exit of operations in Russia
Remaining organic growth/
productivity/other -0.9% -$0.17
• Decline driven by lower sales volumes (particularly electronics/consumer retail);
manufacturing/supply chain headwinds; China (COVID-related); and Europe geopolitical impacts
• Benefits from higher selling prices; aggressive spending discipline; ongoing productivity actions
• Investments in growth, productivity, and sustainability
Restructuring charge -0.5% -$0.05 • Q1 2023 pre-tax charge of $52M versus $18M in Q1 2022
Raw material -1.3% -$0.15 • Carryover impact of raw material, logistics, and energy cost inflation
FX -0.3% -$0.10 • U.S. dollar strength
Divestiture* 0.0% -$0.03 • Food Safety divestiture; Aearo Technologies deconsolidation
Other expense/income NA -$0.02 • Primarily higher non-op pension
Adjusted tax rate** NA $0.00 • Q1 2023 adjusted tax rate of 17.7% versus 17.5% in Q1 2022
Shares outstanding NA +$0.07 • Average diluted shares down 3.8%
Q1 2023 17.9% $1.97
* Includes lost income from divested businesses and remaining stranded costs (net of transition arrangement income).
** The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above.

-- 5 of 20 --

6
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Q1 2023 cash flow and balance sheet
Adjusted free cash flow
$0.9B
Adjusted free cash flow
conversion
87%
Cash returned to
shareholders
$0.9B
Adjusted free cash flow • Q1: $0.9B, up 24% YoY
Adjusted free cash flow
conversion
• Q1: 87%, up 37 ppts YoY
• Q1 YoY increase driven by lower annual incentive cash
compensation and improvement in working capital, primarily
inventory
Adjusted capital
expenditures • Q1: $445M, up 15% YoY
Net debt • Q1: $12.0B, down 10% YoY
Capital returned to
shareholders • Q1: dividends $827M

-- 6 of 20 --

2023 Q1 Earnings | April 25, 2023. All rights reserved.
Business Group performance
Safety &
Industrial
Transportation &
Electronics Health Care Consumer

-- 7 of 20 --

8
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Safety & Industrial
Q1 2023 commentary
• Organic growth performance:
– High-single digit increases in automotive aftermarket, electrical markets,
and abrasives
– Declines in personal safety; industrial adhesives and tapes; and closure and
masking systems
– Disposable respirator/Russia YoY headwind of ~$285M, or -67%
organically; reduced segment organic growth by 9.9 ppts
• Moderating demand and destocking in certain industrial end-markets, most
significantly in Asia and China
• Adjusted operating margin -2.4 ppts YoY
– Decline driven by lower sales volume; manufacturing/supply chain
headwinds; carryover raw material/logistics/energy cost inflation;
investments; and China COVID-related challenges
– Headwinds partially offset by benefits from pricing, aggressive spending
discipline, and productivity actions
Organic growth
-6.0%
Includes ~(9.9) ppt headwind from disposable
respirator decline and 2022 exit of Russia
Adjusted operating margin
20.2%

-- 8 of 20 --

9
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Transportation & Electronics
Q1 2023 commentary
• Adjusted organic growth performance
– Low-double digit increase in automotive and aerospace; high-single digit
increase in advanced materials
– Significant decline in electronics (-35% YoY); single-digit declines in
transportation safety and commercial solutions
• Significant consumer electronics softness continues; weak demand for
smartphones, tablets, and TVs; tiers and OEM’s aggressively reducing
inventories
• Expect sales volumes will improve as consumer electronics markets stabilize
and China recovers in 2H
• Adjusted operating margin -5.5 ppts YoY
– Decline driven by lower sales volume; manufacturing/supply chain
headwinds; carryover raw material/logistics/energy cost inflation;
investments; and China COVID-related challenges
– Headwinds partially offset by benefits from pricing, aggressive spending
discipline, and productivity actions
Adjusted organic growth
-11.3%
Adjusted operating margin
16.7%

-- 9 of 20 --

10
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Health Care
Q1 2023 commentary
• Organic growth performance
– Low-single digit increases in medical solutions and oral care; health
information systems was flat
– High-single digit decline in separation and purification due to normalization
of post-COVID-related biopharma demand
– 2022 exit of Russia reduced segment organic growth by 50 bps YoY
• Healthcare and oral care elective procedure volumes at ~90% of pre-COVID
levels; expect procedure volumes to improve as we progress through the year
• Operating margin -3.0 ppts YoY
– Decline driven by manufacturing/supply chain headwinds; carryover raw
material/logistics/energy cost inflation; and investments
– Headwinds partially offset by benefits from pricing, aggressive spending
discipline, and productivity actions
Organic growth
1.4%
Includes ~(50) bps headwind from
2022 exit of Russia
Operating margin
17.9%

-- 10 of 20 --

11
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Consumer
Q1 2023 commentary
• Organic growth performance
– Low-single digit increase in stationery and office
– Low double-digit decline in home improvement; mid-single digit decline in
home, health, and auto care
• Consumers shifted spending patterns and retailers aggressively reduced
inventory levels relative to Q1 2022; expect cautious discretionary spending as
we move forward through the year
• Operating margin -1.8 ppts YoY
– Decline driven by lower sales volume; manufacturing/supply chain
headwinds; and carryover raw material/logistics/energy cost inflation
– Headwinds partially offset by benefits from pricing, aggressive spending
discipline, and productivity actions
Organic growth
-6.8%
Operating margin
15.0%

-- 11 of 20 --

2023 Q1 Earnings | April 25, 2023. All rights reserved.
2023 Outlook

-- 12 of 20 --

13
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Full-year 2023 guidance remains unchanged
Full-year
Adjusted organic sales growth
-3.0% to flat
Includes ~(2) ppt headwind from disposable
respirator decline and 2022 exit of Russia
Adjusted earnings per share
$8.50 to $9.00
Includes $0.55-$0.80 headwind from disposable
respirator decline, 2022 exit of Russia, FX and divestitures
Adjusted free cash flow conversion
90% to 100%
Q2 2023
• Adjusted sales of $7.7B to $7.9B
• Adjusted EPS of $1.50 to $1.75, includes pre-tax
restructuring charge of $175M to $250M, or
($0.25) to ($0.35) per share
Macroeconomic and end-market trends
• GDP up ~2% YoY; IPI up ~1% YoY
• China impacts and EMEA geopolitical challenges remain
• Continued consumer-facing end-market weakness
• Semiconductor down mid-teens YoY
• Auto builds up low-teen YoY
• Healthcare/oral care procedure volumes similar to Q1
• Industrial end-markets mixed

-- 13 of 20 --

2023 Q1 Earnings | April 25, 2023. All rights reserved.
Q&A Mike Roman
Chairman of the Board & Chief
Executive Officer
Monish Patolawala
Executive Vice President, Chief
Financial & Transformation Officer
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 14 of 20 --

2023 Q1 Earnings | April 25, 2023. All rights reserved.
Appendix

-- 15 of 20 --

16
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Q1 2023 P&L
GAAP ($M)
Q1
2023
Q1
2022 Change
Sales $8,031 $8,829 (9.0)%
Gross profit $3,418 $4,003 (14.6)%
% to sales 42.6% 45.3% (2.7)%
SG&A $1,705 $1,882 (9.3)%
% to sales 21.3% 21.3% —%
R&D & related $472 $480 (1.7)%
% to sales 5.9% 5.4% 0.5%
Operating income $1,241 $1,641 (24.4)%
% to sales 15.4% 18.6% (3.2)%
Net income $976 $1,299 (24.9)%
Earnings per share $1.76 $2.26 (21.9)%

-- 16 of 20 --

17
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Q1 2023 adjusted sales recap
Americas EMEA APAC Worldwide
Organic growth 0.4% (3.9)% (16.7)% (5.6)%
Acquisitions/divestitures (1.6)% (1.0)% (1.0)% (1.3)%
FX (0.4)% (5.0)% (5.3)% (2.8)%
Total growth (1.6)% (9.9)% (23.0)% (9.7)%

-- 17 of 20 --

18
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Business segment information
($M) Adjusted net sales* Q1 2023 adjusted sales growth* Adjusted operating income* Adjusted operating margin*
Business Groups
Q1
2023
Q1
2022
Organic
Growth FX M&A
Total
sales
change
Q1
2023
Q1
2022 Percent
change
Q1
2023
Q1
2022
Safety & Industrial $2,779 $3,051 (6.0)% (2.9)% —% (8.9)% $562 $690 (18.7)% 20.2% 22.6%
Transportation & Electronics $1,705 $2,020 (11.3)% (3.2)% (1.1)% (15.6)% $284 $448 (36.4)% 16.7% 22.2%
Health Care $2,010 $2,128 1.4% (2.7)% (4.3)% (5.6)% $360 $445 (19.2)% 17.9% 20.9%
Consumer $1,192 $1,309 (6.8)% (1.9)% (0.3)% (9.0)% $179 $219 (18.5)% 15.0% 16.8%
Total Operating Business
Segment $1,385 $1,802
Corporate & Unallocated $— $1 $(9) $73
Total $7,686 $8,509 (5.6)% (2.8)% (1.3)% (9.7)% $1,376 $1,875 (26.6)% 17.9% 22.0%
*"Safety & Industrial", "Transportation & Electronics", "Corporate & Unallocated", "Total Operating Business Segment" and "Total" provided on an adjusted basis while
“Health Care” and “Consumer” are not provided on an adjusted basis

-- 18 of 20 --

19
2023 Q1 Earnings | April 25, 2023. All rights reserved.
Additional GAAP sales detail
($M) GAAP Net Sales
Business Groups Q1 2023 Q1 2022
Abrasives 341 329
Automotive Aftermarket 312 295
Closure and Masking Systems 245 258
Electrical Markets 324 309
Industrial Adhesives and Tapes 544 621
Personal Safety 903 1,127
Roofing Granules 110 112
Total Safety & Industrial Business Group 2,779 3,051
Advanced Materials 301 305
Automotive and Aerospace 462 460
Commercial Solutions 432 454
Electronics 672 923
Transportation Safety 183 198
Total Transportation & Electronics Business Group 2,050 2,340
($M) GAAP Net Sales
Business Groups Q1 2023 Q1 2022
Food Safety — 92
Health Information Systems 300 300
Medical Solutions 1,123 1,128
Oral Care 341 348
Separation and Purification Sciences 232 260
Other Health Care 14 —
Total Health Care Business Group 2,010 2,128
Home, Health and Auto Care 400 437
Construction and Home Improvement Markets 529 603
Stationery and Office 263 269
Total Consumer Business Group 1,192 1,309
Corporate and Unallocated — 1
Total 3M 8,031 8,829

-- 19 of 20 --



-- 20 of 20 --